← Eichor
Study identifier: NCT06276452 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Supporting Resilience Among Re-entered Seniors

Condition: Chronic Disease  ·  Sponsor: University of Louisville

PhaseNA
Planned participants8
Who can joinMale, 45 Years to no upper limit
Healthy volunteersYes

About this study

The first goal (Aim 1) of this clinical trial is to learn about specific strengths, challenges, and desired areas of knowledge and skill-building among older adults who re-entered their communities from a period of incarceration and to then develop a new psychoeducational intervention tailored to these older adults. The second goal (Aim 2) of this clinical trial is to test if the intervention increases chronic disease management and whether the intervention is considered appropriate and acceptable by older adults who re-entered their communities from a period of incarceration. Aim 1 participants will: * complete a baseline survey * participate in a focus group Aim 2 participants will: * complete a baseline survey * participate in an 8-week once weekly intervention * complete three follow up surveys

This description comes directly from the study's public registry record.

Talk to the study team

Stephanie Grace Prost, PhD  ·  850-491-0285  ·  stephanie.prost@louisville.edu

Always discuss trial participation with your own doctor first.

Locations (1)

New Legacy ReentryLouisville, Kentucky, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06276452